02May/13

Fluidigm Management Discusses Q1 2013 Results – Earnings Call Transcript – Seeking Alpha

Fluidigm Management Discusses Q1 2013 Results – Earnings Call Transcript
Seeking Alpha
We are happy to report that the DKMS has scaled it’s NGS-based HLA typing operations to thousands of samples per week which wouldn’t have been practical without the workflow, cost and performance benefits of the Access Array. A segment of the HLA
Fluidigm Reports Strong Q1 2013 ResultsEON: Enhanced Online News (press release)

all 2 news articles »

01May/13

Fluidigm Reports Strong Q1 2013 Results – Wall Street Journal (press release)

Fluidigm Reports Strong Q1 2013 Results
Wall Street Journal (press release)
HLA typing emerged as a high-throughput production genomics application for Fluidigm’s Access Array System. The DKMS Life Science Lab (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft mbH) scaled its HLA typing operations to
Fluidigm Management Discusses Q1 2013 Results – Earnings Call TranscriptSeeking Alpha

all 3 news articles »

01May/13

Fluidigm Reports Strong Q1 2013 Results – Business Wire (press release)

Fluidigm Reports Strong Q1 2013 Results
Business Wire (press release)
HLA typing emerged as a high-throughput production genomics application for Fluidigm’s Access Array System. The DKMS Life Science Lab (Deutsche Knochenmarkspenderdatei gemeinnützige Gesellschaft mbH) scaled its HLA typing operations to
Fluidigm Management Discusses Q1 2013 Results – Earnings Call TranscriptSeeking Alpha

all 3 news articles »